Department of Radiation Oncology, Division of Molecular Radiation Biology and Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas 75390-9187, USA.
Radiat Res. 2010 Jul;174(1):62-71. doi: 10.1667/RR2157.1.
The purpose of this study was to develop a rat orthotopic lung tumor model with a solitary intrapulmonary nodule to study the effects of high-dose radiation. A549-Luc non-small cell lung cancer (NSCLC) cells were implanted into nude rats in the intercostal space between ribs 5 and 6 of the right lung. Bioluminescence and microcomputed tomography (CT) imaging were performed after implantation to confirm the presence of a solitary tumor and to monitor tumor growth. A device using image guidance for localization was developed to facilitate high-precision irradiation in small animals. A pilot irradiation study was performed, and response was assessed by bioluminescence imaging and immunohistochemistry. Radiation response was confirmed through serial bioluminescence imaging, and the strength of the bioluminescence signal was observed to be inversely proportional to dose. Response was also observed by the monoclonal antibody bavituximab, which binds to exposed lipid phosphatidylserine (PS) on tumor vessels. The ability to (1) reproducibly generate solitary tumor nodules in the rat lung, (2) identify and monitor tumor growth by bioluminescence imaging and CT imaging, (3) accurately target these tumors using high doses of radiation, and (4) demonstrate and quantify radiation response using bioluminescence imaging provides significant opportunity to probe the biological mechanisms of high-dose irradiation in preclinical settings.
本研究旨在建立一个具有孤立性肺内结节的大鼠原位肺肿瘤模型,以研究大剂量辐射的影响。将 A549-Luc 非小细胞肺癌(NSCLC)细胞植入裸鼠右侧第 5 和第 6 肋间隙的肋间。植入后进行生物发光和微计算机断层扫描(CT)成像,以确认存在孤立性肿瘤并监测肿瘤生长。开发了一种使用图像引导进行定位的设备,以方便小动物的高精度照射。进行了一项初步照射研究,并通过生物发光成像和免疫组织化学评估反应。通过连续的生物发光成像确认了放射反应,并且观察到生物发光信号的强度与剂量成反比。还通过单克隆抗体 bavituximab 观察到反应,该抗体结合肿瘤血管上暴露的脂质磷脂酰丝氨酸(PS)。该方法具有以下优点:(1)能够在大鼠肺中重现性地生成孤立性肿瘤结节;(2)通过生物发光成像和 CT 成像来识别和监测肿瘤生长;(3)使用高剂量辐射准确靶向这些肿瘤;(4)通过生物发光成像来证明和量化放射反应。这些优势为在临床前环境中探究大剂量照射的生物学机制提供了重要机会。